New pneumonia vaccine shows promise in early trial
NCT ID NCT05092386
First seen Feb 01, 2026 · Last updated May 19, 2026 · Updated 14 times
Summary
This early-stage trial tested a new 13-valent pneumococcal conjugate vaccine in 310 healthy people aged 6 weeks and older. The goal was to check the vaccine's safety and how well it triggers an immune response. Results will help decide if larger studies are needed to confirm protection against pneumococcal infections like pneumonia and meningitis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Henan Center for Diseases Control and Prevention
Zhengzhou, Henan, China
Conditions
Explore the condition pages connected to this study.